Search clinical trials for: Sodium-glucose cotransporter 2 inhibitor
Total 9207 results
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Austria, Germany
-
Brigham and Women's HospitalCompleted
-
Sichuan Academy of Medical SciencesRecruitingPeritoneal Dialysis Complication | Renal Function Aggravated | Sodium-glucose Co-transporter-2 InhibitorsChina
-
Handok Inc.Not yet recruiting
-
University of Colorado, DenverRecruitingVascular Diseases | Diabetes | Kidney Transplant; ComplicationsUnited States
-
The First Affiliated Hospital of Dalian Medical...Recruiting
-
Juntendo UniversityBoehringer IngelheimRecruiting
-
Dong-A UniversityRecruitingRenal Insufficiency, Chronic | Percutaneous Coronary Intervention | Cardiac CatheterizationKorea, Republic of
-
University of OklahomaRecruitingDiabetes Mellitus | Atrial FibrillationUnited States
-
RenJi HospitalRecruitingHemodialysis ComplicationChina
-
Jacob MollerRigshospitalet, Denmark; University Hospital Bispebjerg and Frederiksberg; Hillerod... and other collaboratorsRecruitingHeart Failure | ObesityDenmark
-
Xiangtan Central HospitalZhuZhou Central Hospital; Second Xiangya Hospital of Central South UniversityRecruitingHeart Failure | AnemiaChina
-
Andrea GiaccariRecruitingType2 Diabetes Mellitus | Stable Coronary Artery DiseaseItaly
-
Boehringer IngelheimActive, not recruitingLiver Diseases | Hypertension, PortalSpain, Denmark, Singapore, Germany, Italy, Austria, Canada, Netherlands, China, Israel, Belgium, United States, Japan, Argentina, France, Romania
-
University of PennsylvaniaAmgenCompleted
-
University of LiverpoolAstraZeneca; Clinical Practice Research DatalinkActive, not recruitingType 2 Diabetes MellitusUnited Kingdom
-
Mansoura UniversityCompletedAcute Heart FailureEgypt
-
University Hospital Inselspital, BerneBoehringer Ingelheim; University of BernCompleted
-
Postgraduate Institute of Medical Education and...CompletedPancreatic LipomatosisIndia
-
Ain Shams UniversityCompletedPharmacokinetics | PharmacogenomicEgypt
-
CHEOL WHAN LEE, M.D., Ph.DTerminatedCoronary Artery Disease | Prediabetic StateKorea, Republic of
-
National Institute on Aging (NIA)CompletedPhysiological Effects of Drugs | Hypoglycemic Agents | Empaglifozin | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Mario Negri Institute for Pharmacological ResearchBoehringer IngelheimWithdrawnObesity | Non-diabetic Chronic Kidney Disease
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Korea, Republic of, China, Germany, Belgium, Australia, Italy, United Kingdom, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, Mexico, India, Brazil, France
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
University of MiamiAstraZenecaCompleted
-
Novartis PharmaceuticalsCompletedPolycystic Ovary SyndromeGermany, United States
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Germany, Greece, Australia, Sweden, Italy, Norway, Poland, Portugal
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType II Diabetes MellitusUnited States
-
Yonsei UniversityCompletedType 2 Diabetes MellitusKorea, Republic of
-
Radboud University Medical CenterCompletedHypoglycemia | Diabetes Mellitus, Type 1 | Hypoglycemia UnawarenessNetherlands
-
Yaounde Central HospitalCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
AstraZenecaBristol-Myers SquibbCompleted
-
AstraZenecaBristol-Myers SquibbCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedHypertension | Diabetes Mellitus, Type 2United States, Canada, Czech Republic, Denmark, Estonia, Finland, France, Germany, Lebanon, Netherlands, Norway, Sweden
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
University of Erlangen-Nürnberg Medical SchoolCompleted
-
Hannover Medical SchoolBoehringer IngelheimNot yet recruitingAutosomal Dominant Polycystic Kidney
-
McGill University Health Centre/Research Institute...Heart and Stroke Foundation of CanadaNot yet recruitingESRD, CKD Stage 4, CKD Stage 5
-
Ottawa Heart Institute Research CorporationNot yet recruitingMyocardial Infarction | ST Elevation Myocardial InfarctionCanada
-
Chulalongkorn UniversityNot yet recruitingEmpagliflozin in Cardiorenal Syndrome Type 1Thailand
-
Northwestern UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...RecruitingHeart Failure | Kidney Diseases | Chronic Kidney Diseases | Heart Failure With Preserved Ejection FractionUnited States
-
University Health Network, TorontoNot yet recruitingEnd Stage Kidney Disease | Kidney Dysfunction | Peritoneal Dialysis Complication | Sodium-glucose Co-transporter-2 Inhibitors | Residual Kidney FunctionCanada
-
Albina Nowak, MDNot yet recruiting
-
Chinese University of Hong KongRecruitingAcute Heart FailureHong Kong
-
Chulalongkorn UniversityRecruitingEmpagliflozin in Post AKI Stage 2-3Thailand
-
Tor Biering-SørensenRecruitingChronic Kidney DiseasesDenmark